Andrea Riposati is the CEO and also co-founder of Dante Labs. The company was started in New York City in 2016. Dante Labs is a company that has advanced in whole genome sequencing.
What is Whole Genome Sequencing
Andrea Riposati explains that it is the study of a person’s whole DNA. He explains that a person’s DNA is what makes all organs work and what diseases we are at risk of getting. It is also responsible for how our body reacts to food or medicines.
Most of the clients do not know all the applications of whole genome sequencing technology. Each person will undergo the test for personal reasons.
The reason for the launch of Dante Labs
It was Andrea’s mission to solve a serious problem. A friend of his needed a genetic test. Andrea then thought that there has to be more people who needed such a test and that is what made him develop a solution. He founded Dante Labs with Mattia Capulli who was his high school friend.
What motivated Andrea Riposati to keep going
One was when he learned about genomics and all the potential it has. He could help people by detecting rare diseases, cancer, and many more. This fascinated him a lot.
He also came to realize that not everyone can get access to the tests. This motivated him to find a way to make it available to as many people as possible.
The cost of the whole genome sequencing test has been expensive. He has tried to make sure that people get access to these WGS tests in different countries at the same cost and with all interests.
The secret behind the growth of Dante Labs
Andrea says that the will that drives him and his co-workers is what fuels the growth of the company. Their goal is to bring spread genome sequencing technology to as many countries as they can.